Anxiety medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 79: Line 79:
Preferred regimen for [[Social anxiety]]:
Preferred regimen for [[Social anxiety]]:
* [[SSRIs]] and [[beta-blockers]] <nowiki/> for [[social anxiety disorder]].
* [[SSRIs]] and [[beta-blockers]] <nowiki/> for [[social anxiety disorder]].
===Psychotherapy===
*[[CBT]] is a type of [[psychotherapy]] that can help people with [[anxiety]] disorders. It teaches a person different ways of thinking, behaving, and reacting to [[anxiety]]-producing and fearful situations. [[Cognitive-behavioral therapy|CBT]] can also help people learn and practice [[social skills]], which is vital for treating [[social anxiety disorder]].
*Two specific stand-alone components of [[CBT]] used to treat [[social anxiety disorder]] are [[cognitive]] therapy and [[exposure]] therapy. [[Cognitive therapy]] focuses on identifying, challenging, and then neutralizing unhelpful thoughts underlying [[anxiety]] disorders.
*[[Exposure therapy]] focuses on confronting the fears underlying an [[anxiety]] [[Disorder (medicine)|disorder]] in order to help people engage in activities they have been avoiding. [[Exposure therapy]] is used along with relaxation exercises and/or imagery. One study, called a [[meta-analysis]] because it pulls together all of the previous studies and calculates the statistical magnitude of the combined effects, found that [[cognitive therapy]] was superior to exposure therapy for treating [[Social anxiety disorder|social anxiety]] disorder.
*[[CBT]] may be conducted individually or with a group of people who have similar problems. [[Group therapy]] is particularly effective for [[social anxiety]] disorder. Often “homework” is assigned for participants to complete between sessions.<ref name="pmid26795939">{{cite journal |vauthors=Kivity Y, Huppert JD |title=Does cognitive reappraisal reduce anxiety? A daily diary study of a micro-intervention with individuals with high social anxiety |journal=J Consult Clin Psychol |volume=84 |issue=3 |pages=269–83 |year=2016 |pmid=26795939 |doi=10.1037/ccp0000075 |url=}}</ref>
* Meditation may be better than relaxation<ref name="pmid31322102">{{cite journal| author=Montero-Marin J, Garcia-Campayo J, Pérez-Yus MC, Zabaleta-Del-Olmo E, Cuijpers P| title=Meditation techniques v. relaxation therapies when treating anxiety: a meta-analytic review. | journal=Psychol Med | year= 2019 | volume= 49 | issue= 13 | pages= 2118-2133 | pmid=31322102 | doi=10.1017/S0033291719001600 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31322102  }} </ref>.


==References==
==References==

Revision as of 03:26, 23 November 2022

Anxiety Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anxiety from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anxiety medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anxiety medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anxiety medical therapy

CDC on Anxiety medical therapy

Anxiety medical therapy in the news

Blogs on Anxiety medical therapy

Directions to Hospitals Treating Anxiety

Risk calculators and risk factors for Anxiety medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

The mainstay of therapy for anxiety is the administration of pharmacotherapy and psychotherapy. Mostly used Antidepressants , Benzodiazepines (some concern over dependency), buspirone, tricyclic antidepressants , SSRIs (selective serotonin reuptake inhibitors).

Medical Therapy

Pharmacotherapy

Systematic reviews guide treatment of generalized anxiety disorder[1][2][3]:

Evidence summary from NICE of selected medications.[3]
  Evidence base Relative risk of
non-response
Relative risk of
Drug toxicity
Sertraline Trials: 2
(706 patients)
0.70* 1.1
Nausea
Sexual
Venlafaxine Trials: 12
(3470 patients)
0.80* 2.06*
Nausea
Sexual
Insomnia
Citalopram Trials: 1
(34 patients)
0.46* 3.0
Escitalopram Trials: 6
(2136 patients)
0.78 1.72*
Nausea
Sexual
Paroxetine Trials: 8
(2748 patients)
0.91 2.5*
Nausea
Sexual
Insomnia
Pregabalin Trials: 8
(2079 patients)
0.79* 1.3
Dizziness
Fatigue
Buspirone Trials: 5
(806 patients)
0.87 2.0*
Nausea
Dizziness
Hydroxyzine Trials: 3
(482 patients)
0.81 1.48
Little short term toxicity
Alprazolam Trials: 4
(544 patients)
0.87 1.3
Little short term toxicity
* P< 0.05

SSRIs:

The first line treatment for generalized anxiety disorder is SSRI:

  • Preferred regimen:
    • Sertraline oral dose of 25 mg once daily for 1 week, increase it based on response and tolerability; maximum dose is 200mg/day.
  • Alternative regimen:
    • Alternative regimen (1): Citalopram (Celexa): Oral (initial dose-10mg) with daily dose ranging from 10-40mg.
    • Alternative regimen (2): Escitalopram (Lexapro): Oral (initial dose-5-10mg) with daily dose ranging from 10-20mg.
    • Alternative regimen (3): Paroxetine ( Paxil): Oral(initial dose 20mg) with daily dose ranging from 20-50mg.
    • Usually SSRIs are most effective at highest tolerable doses.

Other medications

Consider[2]:

  • Bupropion
  • Hydroxyzine

Alternative regimens from other categories:

SNRI's:

  • Preferred regimen (1): Duloxetine: Oral (initial dose 30mg) with daily dose ranging from 60-120mg.
  • Preferred regimen (2): Venlafaxine: Oral (initial dose 75mg) with daily dose ranging from 75-225mg.

Benzodiazepines:

  • These medications are used as alternative or short term therapy:
    • Alternative regimen (1): Lorazepam (Ativan) - Started at 0.5-1mg orally t.i.d. and titrated up to 1.5mg q.i.d daily as needed.
    • Alternative regimen (2): Diazepam (Valium) started at 2.5mg to 5mg orally once or twice daily and titrated up to 10mg ,two or three times daily as needed.
    • Alternative regimen (3): Clonazepam (Klonopin) can be started at 0.25-0.5 mg orally once or twice daily and titrated up to 1mg (b.i.d or t.i.d) daily as needed.
    • There is increased risk of dependence and tolerance, so maintain caution in long term use, SSRIs are therefore first line treatment for anxiety disorders in long term use.

Other drugs to consider:

  • Other medications that may be used include:
    • Alternative regimen (1): Buspirone (Buspar)- initial dose is 10mg with daily dose ranging from 10-60mg.
    • Alternative regimen (2): Pregabalin (Lyrica)- initial dose is 50mg with daily dose ranging from 50-300mg.
    • Alternative regimen (3): Second generation anti psychotics like Quetiapine( SEROQUEL)- Start with initial dose of 25mg/day and titrated at 25-50mg intervals weekly or biweekly to a maximum dose of 300mg/day.
    • Alternative regimen (7): Hydroxyzine (Vistaril)- doses between 50 to 150 mg a day in divided doses as PRN, is effective for anxiety disorders.
    • Alternative regimen (8): Mirtazapine (Remeron)_ doses between 15 mg to 45 mg used as monotherapy or adjunctive treatment in Generalized anxiety disorder.

Preferred regimen for Panic disorder:

  • SSRIs, SNRIs, benzodiazepines preferred regimen in acute exacerbation and as needed basis. Doses are used in the same range as for generalized anxiety disorders.

Preferred regimen for Social anxiety:

References

  1. Chawla N, Anothaisintawee T, Charoenrungrueangchai K, Thaipisuttikul P, McKay GJ, Attia J; et al. (2022). "Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials". BMJ. 376: e066084. doi:10.1136/bmj-2021-066084. PMID 35045991 Check |pmid= value (help).
  2. 2.0 2.1 Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N (2019). "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis". Lancet. 393 (10173): 768–777. doi:10.1016/S0140-6736(18)31793-8. PMID 30712879.
  3. 3.0 3.1 National Institute for Health and Clinical Excellence (2011). Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults

Template:WH Template:WS